Stephen E Jones Selected Research

Stephen E Jones Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 08/2017 - 04/2002
8	Neoplasms (Cancer) 08/2013 - 06/2002
5	Multiple Sclerosis 01/2023 - 10/2018
4	Pain (Aches) 02/2021 - 10/2007
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
4	Disease Progression 06/2008 - 07/2003
3	Cognitive Dysfunction 01/2021 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
2	Stroke (Strokes) 10/2023 - 01/2023
2	Progressive Multifocal Leukoencephalopathy 12/2021 - 06/2018
2	Epilepsy (Aura) 01/2014 - 02/2012
2	Vaginal Discharge 10/2007 - 02/2006
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Cerebral Cortical Thinning 11/2020
1	Memory Disorders (Memory Loss) 11/2020
1	Aneurysm (Aneurysms) 03/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Overactive Urinary Bladder (Overactive Bladder) 12/2017
1	Dementia (Dementias) 01/2016
1	Ganglion Cysts (Ganglion) 01/2016
1	Drug Resistant Epilepsy 05/2014
1	Glioma (Gliomas) 06/2013
1	Edema (Dropsy) 06/2013
1	Headache Disorders (Headache Syndromes) 02/2012
1	Migraine Disorders (Migraine) 02/2012
1	Facial Hemiatrophy (Parry-Romberg Syndrome) 02/2012
1	Partial Epilepsies (Epilepsy, Partial) 02/2012
1	Atrophy 02/2012
1	Secondary Headache Disorders 02/2012
1	Epilepsia Partialis Continua 02/2012
1	Tension-Type Headache (Tension Headache) 02/2012
1	Hypertension (High Blood Pressure) 01/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2011
1	Hot Flashes 10/2007
1	Osteoporosis 09/2007
1	Endometrial Neoplasms (Endometrial Cancer) 09/2007
1	Pulmonary Embolism 12/2006
1	Retinal Degeneration 04/2004
1	Injection Site Reaction 10/2003
1	Nausea 10/2003

Drug/Important Bio-Agent (IBA)

16	Tamoxifen FDA LinkGeneric 08/2013 - 04/2002
11	exemestane (Aromasin)FDA Link 08/2013 - 04/2002
7	Hormones (Hormone)IBA 08/2013 - 10/2003
5	Fulvestrant (Faslodex)FDA Link 07/2005 - 10/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 06/2002
4	Docetaxel (Taxotere)FDA Link 08/2017 - 12/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 06/2002
4	Estrogen ReceptorsIBA 03/2012 - 06/2002
4	Anastrozole (Arimidex)FDA LinkGeneric 07/2005 - 04/2002
3	Retinaldehyde (Retinal)IBA 01/2020 - 01/2016
3	Trastuzumab (Herceptin)FDA Link 10/2013 - 01/2008
3	Aromatase InhibitorsIBA 01/2011 - 04/2002
2	GadoliniumIBA 01/2023 - 03/2019
2	IronIBA 12/2021 - 02/2012
2	Natalizumab (Tysabri)FDA Link 12/2021 - 06/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	AnthracyclinesIBA 08/2017 - 10/2013
2	Estrogen Receptor AntagonistsIBA 04/2005 - 10/2003
2	Estrogen Receptor Modulators (Antiestrogen)IBA 04/2005 - 10/2003
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	Contrast MediaIBA 01/2023
1	Myelin ProteinsIBA 10/2018
1	hydroxide ionIBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 08/2017
1	SteroidsIBA 06/2013
1	erucylphosphocholineIBA 02/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2009
1	taxaneIBA 06/2008
1	A 7 (A-7)IBA 10/2007
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 12/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2006
1	MitogensIBA 04/2006
1	Proteins (Proteins, Gene)FDA Link 04/2006
1	MAP Kinase Kinase 3IBA 04/2006
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2006
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2004
1	NeurturinIBA 04/2004
1	Selective Estrogen Receptor Modulators (SERM)IBA 03/2003
1	LY 353381 (LY353381)IBA 03/2003
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2002
1	Aromatase (CYP19)IBA 04/2002
1	Letrozole (Femara)FDA LinkGeneric 04/2002

Therapy/Procedure

18	Therapeutics 01/2022 - 04/2002
3	Deep Brain Stimulation 01/2023 - 05/2014
2	Transcranial Direct Current Stimulation 10/2023 - 01/2017
2	Electrodes (Electrode) 05/2014 - 01/2014
2	Adjuvant Chemotherapy 06/2008 - 06/2002
2	Drug Therapy (Chemotherapy) 06/2008 - 01/2008
1	Neurosurgical Procedures 05/2014
1	Segmental Mastectomy (Lumpectomy) 08/2013
1	Radiotherapy 08/2013
1	Lasers (Laser) 06/2013
1	Intramuscular Injections 10/2002
1	Ambulatory Care (Outpatient Care) 10/2002
1	Palliative Care (Palliative Therapy) 10/2002